2024
Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Li D, Zhang J, Zhang X, Chang Y, Vermund S. Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Research Archives 2024, 12: 10.18103/mra.v12i4.5205. PMID: 39118854, PMCID: PMC11309002, DOI: 10.18103/mra.v12i4.5205.Peer-Reviewed Original ResearchHuman immunodeficiency virus/acquired immunodeficiency syndromeHuman immunodeficiency virusHuman immunodeficiency virus-infected womenAdherence to antiretroviral therapyNeonatal outcomesImmunodeficiency virusImmunodeficiency syndromeIntensive care unitAntiretroviral therapySARS-CoV-2Maternal mortalityRisk of mother-to-child transmissionVertical transmissionVertical transmission of human immunodeficiency virusClinical managementTransmission of human immunodeficiency virusImpact of human immunodeficiency virusIncreased risk of maternal mortalityHuman immunodeficiency virus controlPoor adherence to antiretroviral therapySARS-CoV-2 vertical transmissionVertical transmission of SARS-CoV-2Pregnant individualsMother-to-child transmissionNeonatal intensive care unit
1997
Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study.
Tuomala RE, Kalish LA, Zorilla C, Fox H, Shearer W, Landay A, Vermund SH, Landesman S, Burns D. Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstetrics And Gynecology 1997, 89: 967-74. PMID: 9170476, DOI: 10.1016/s0029-7844(97)00129-4.Peer-Reviewed Original ResearchConceptsTotal lymphocyte countFirst postpartum yearLymphocyte countYear postpartumCell countCD8 percentagesNonpregnant cohortLymphocyte subsetsPostpartum yearHuman immunodeficiency virus-infected womenCD4/CD8 ratioInfants Transmission StudyHuman immunodeficiency virusImmediate postpartum periodCD4 percentMean CD4Nonpregnant HIVRelative CD4CD8 ratioAbsolute CD4Lymphocyte parametersNonpregnant womenImmunodeficiency virusPregnant womenPostpartum period
1991
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection
Vermund S, Kelley K, Klein R, Feingold A, Schreiber K, Munk G, Burk R. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. American Journal Of Obstetrics And Gynecology 1991, 165: 392-400. PMID: 1651648, DOI: 10.1016/0002-9378(91)90101-v.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionSquamous intraepithelial lesionsHuman papillomavirus infectionImmunodeficiency virus infectionSymptomatic human immunodeficiency virus infectionHuman immunodeficiency virusIntraepithelial lesionsPapillomavirus infectionVirus infectionUninfected womenImmunodeficiency virusHigh riskHuman immunodeficiency virus-infected womenHuman immunodeficiency virus-related diseaseHuman immunodeficiency virus seropositiveCervical squamous intraepithelial lesionsHigh-risk womenCervical cytologic abnormalitiesVirus-related diseasesPublic health measuresAssociated immunosuppressionAsymptomatic womenCytologic abnormalitiesHuman papillomavirusHealth measures